en

PRODUCT DETAIL

Revlimid 25 mg tvrdé kapsuly

Code 43536
MA number EU/1/07/391/004
Product Form: cps dur 21x25 mg (blis. PCTFE/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Bristol-Myers Squibb Pharma EEIG , Ireland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX04 Lenalidomide
Shelf life: 36
Container: blister PCTFE/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 14.06.2007
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Revlimid 7 11 2016.pdf  
Dokument: DHPC 2 Revlimid_SUKL_8 4 2011.pdf  
Dokument: DHPC Revlimid 19 10 2011.pdf  
Dokument: DHPC Revlimid_SUKL_clean.doc  
Safety feature Yes
Data update: 11.06.2019
eu-flag.png sk-flag.png